Can intravenous (IV) contrast be given during the first trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Contrast Use During First Trimester of Pregnancy

IV iodinated contrast can be administered during the first trimester of pregnancy when the potential benefit outweighs the risk, but gadolinium-based contrast agents should be avoided unless absolutely essential to maternal or fetal health. 1, 2, 3

Iodinated Contrast Media (for CT)

  • Iodinated contrast agents are generally considered safe during pregnancy, including the first trimester, but should only be administered when clinically necessary and when the potential diagnostic information outweighs any potential risks 1, 4
  • When CT imaging is required during pregnancy, iodinated contrast can be used with caution, particularly when the diagnostic information is essential for maternal care 1
  • The primary concern with iodinated contrast during pregnancy is the theoretical risk of fetal hypothyroidism, though this risk appears to be minimal in clinical practice 4

Gadolinium-Based Contrast Agents (for MRI)

  • Gadolinium-based contrast agents should be avoided during pregnancy, particularly in the first trimester, unless absolutely essential to maternal or fetal health 2, 3
  • Gadolinium crosses the placenta and enters fetal circulation where it can accumulate in amniotic fluid and fetal tissues 2, 5
  • The FDA classifies gadolinium as a pregnancy category C drug, indicating it should only be used if the benefits outweigh the risks 3
  • Studies have found associations between gadolinium exposure during pregnancy and increased risk of rheumatologic, inflammatory, or infiltrative skin conditions in offspring, as well as potential increased risk of stillbirth or neonatal death 2, 5
  • First trimester exposure to gadolinium is particularly concerning, with one study identifying higher rates of exposure during early pregnancy, often before pregnancy is recognized 6

Imaging Considerations During Pregnancy

  • Non-contrast MRI is considered safe in all trimesters of pregnancy and is preferred over CT when ultrasound is inadequate 2
  • Ultrasound remains the first-line imaging modality for most conditions during pregnancy, with MRI serving as a complementary or problem-solving tool 2, 1
  • When contrast-enhanced imaging is necessary during pregnancy, the risks of potential misdiagnosis due to withholding contrast agents must be weighed against the potential risks to the fetus 4, 7

Clinical Decision Algorithm

  1. First, determine if imaging is absolutely necessary for diagnosis
  2. If imaging is necessary, consider non-radiation options first (ultrasound)
  3. If advanced imaging is required:
    • For MRI: Use non-contrast protocols whenever possible 2
    • For CT: Iodinated contrast can be used when clinically indicated 4, 7
  4. If contrast is deemed necessary:
    • For iodinated contrast: Can be administered with appropriate clinical justification 1, 4
    • For gadolinium: Avoid unless absolutely essential to maternal or fetal health 2, 3
  5. Document the clinical rationale for contrast administration and obtain informed consent after discussing risks and benefits 1

Common Pitfalls and Caveats

  • Assuming all contrast agents carry the same risk during pregnancy - iodinated contrast is generally considered safer than gadolinium 2, 4
  • Failing to document the clinical necessity for contrast administration during pregnancy 1
  • Not obtaining proper informed consent after discussing the risks and benefits of contrast administration 1, 4
  • Automatically withholding contrast when it could provide essential diagnostic information that outweighs the potential risks 4, 7

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.